BOLD
Boundless Bio, Inc.
2.70$
+2.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -9.6% | -9.9% | +60.8% | -7.0% | +17.9% | -7.3% | -6.2% | -6.0% | -6.9% | -10.2% | -47.7% | |
| – | -8.6% | -9.7% | +63.3% | -6.9% | -9.4% | -9.1% | -7.6% | -7.4% | -8.8% | -13.7% | -22.2% | |
| – | +13.1% | +6.1% | +24.7% | +28.2% | -33.9% | -43.1% | -2.8% | +1.9% | +19.3% | -2.2% | +15.6% | |
| – | -9.0% | -13.1% | +70.9% | -6.8% | -9.0% | -9.1% | -8.0% | -7.5% | -8.5% | -13.7% | -21.8% | |
| – | -1.1% | +0.5% | -96.5% | +11.8% | +457.1% | -2.0% | +3.9% | +3.2% | -0.3% | -6.5% | -85.8% | |
| – | -9.9% | +13.7% | -15.8% | +11.8% | -18.7% | -22.1% | +45.4% | +28.6% | +5.8% | -23.6% | -18.9% | |
| – | -15.6% | -30.6% | -45.0% | -85.5% | – | – | +648.5% | +55.6% | +3.8% | +3.7% | – | |
| – | +174.7% | +32.2% | -42.6% | +50.8% | -49.9% | +7.2% | +67.9% | -50.5% | +31.3% | +36.5% | +145.5% | |
| – | – | – | – | -7.9% | -8.7% | -9.3% | -10.2% | -10.2% | -10.5% | -12.4% | -23.6% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -1.0% | +1.0% | -23.7% | +31.3% | +0.3% | +0.1% | -0.1% | +0.2% | +0.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.